Novavax (NVAX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.30 -5.58%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Oracle raises full year profit guidance, stock rises after hours
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
